Modafinil prevents the MPTP-induced increase in GABAA receptor binding in the internal globus pallidus of MPTP-treated common marmosets

Neuroscience Letters

Volumn 354, Issue 1, 2004, Pages 6-9

  Zeng, B Y ^a   Smith, L A ^a   Pearce, R K B ^a   Tel, B ^a   Chancharme, L ^b   Moachon, G ^b   Jenner, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Laboratoire L Lafon   (France)

Author keywords

Modafinil; MPTP treatment; Primates

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID A RECEPTOR; ANTIPARKINSON AGENT; FLUNITRAZEPAM; MODAFINIL; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPARKINSONIAN ACTIVITY; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; CORPUS STRIATUM; DENSITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG BINDING; DRUG EFFECT; DRUG RECEPTOR BINDING; EXTRAPYRAMIDAL SYNDROME; FEMALE; GABAERGIC SYSTEM; GLOBUS PALLIDUS; MALE; MARMOSET; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0346155930     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.08.038     Document Type: Article

References (16)

1. Aguirre J.A., Cintra A., Hillion J., Narvaez J.A., Jansson A., Antonelli T., Ferraro L., Rambert F.A., Fuxe K. A stereological study on the neuroprotective actions of acute modafinil treatment on 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced nigral lesions of the male black mouse. Neurosci. Lett. 275:1999;215-218.
2. Bastuji H., Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog. Neuropsychopharmacol. Biol. Psychiatry. 12:1988;695-700.
3. A receptor in the striatopallidal complex. Brain Res. 680:1995;43-52.
4. Ferraro L., Antoneli T., O'Connor W.T., Tanganelli S., Rambert F.A., Fuxe K. The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus. NeuroReport. 8:1997;2883-2887.
5. Ferraro L., Antoneli T., O'Connor W.T., Tanganelli S., Rambert F.A., Fuxe K. The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci. Lett. 253:1998;135-138.
6. 3 receptor. Neurosci. Lett. 220:1996;5-8.
7. Ferraro L., Tanganelli S., O'Connor W.T., Antoneli T., Rambert F.A., Fuxe K. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur. J. Pharmacol. 306:1996;33-39.
8. Fuxe K., Janson A.M., Rosen L. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis. Exp. Brain Res. 88:1992;117-130.
9. Janson A.M., Fuxe K., Goldstein M. The MPTP model of Parkinson's disease in the mouse. Modafinil - a new potential neuroprotective agent. Fuxe K., Agnati L., Bjelke B. Trophic Regulation of the Basal Ganglia. Focus on Dopamine Neurones. 1994;409-423 Pergamon Press, Oxford.
10. Jenner P., Zeng B.-Y., Pearce R.K.B., Tel B., Smith L.A., Chancharme L., Moachon G. Antiparkinsonian neuroprotective effects of modafinil in MPTP-treated common marmoset. Exp. Brain Res. 133:2000;178-188.
11. Lagarde D., Anton G. Comparative study of stimulant effects of D-amphetamine sulfate and modafinil, an original psychostimulant. Eur. J. Pharmacol. 183:1990;1476-1481.
12. Tanganelli S., Fuxe K., Ferraro L., Janson A.M., Bianchi C. Inhibitory effects of the psychoactive drug modafinil on γ-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanisms. Naunyn Schmiedebergs Arch. Pharmacol. 345:1992;461-465.
13. Tanganelli S., Perez de la Mora M., Ferraro L. Modafinil and cortical r-aminobutyric acid outflow modulation by 5-hydroxytryptamine neurotoxins. Eur. J. Pharmacol. 273:1995;63-71.
14. Ueki A., Rosen L., Andbjer B., Agnati L.F., Hallstrom A., Goiny M., Tanganelli S., Ungerstedt U., Fuex K. Evidence for a preventive action of the vigilance-promoting drug modafinil against striatal ischemic injury induced by endothelin-1 in the rat. Exp. Brain Res. 96:1993;89-99.
15. Ueki A., Rosen L., Andbjer B., Finnnman U.-B., Altamini U., Janson A.M., Goldsein M., Agnati L.F., Fuex K. The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactive and of DA stores in nigrostriatal DA neurones in the male rat after a partial transection of the DA pathway. Exp. Brain Res. 93:1993;259-270.
16. Waldvogel H.J., Faull R.L.M., Jansen K.L.R., Dragunow M., Richards J.G., Mohler H., Streit P. GABA, GABA receptors and benzodiazepine receptors in the human spinal cord: an autoradiograhic and immunohistochmeical study at the light and electron microscopic levels. Neuroscience. 39:1990;361-385.